Cargando…
LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival
Epithelial dysfunction and crypt destruction are defining features of inflammatory bowel disease (IBD). However, current IBD therapies targeting epithelial dysfunction are lacking. The nuclear receptor LRH-1 (NR5A2) is expressed in intestinal epithelium and thought to contribute to epithelial renewa...
Autores principales: | Bayrer, James R., Wang, Hongtao, Nattiv, Roy, Suzawa, Miyuki, Escusa, Hazel S., Fletterick, Robert J., Klein, Ophir D., Moore, David D., Ingraham, Holly A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180039/ https://www.ncbi.nlm.nih.gov/pubmed/30305617 http://dx.doi.org/10.1038/s41467-018-06137-w |
Ejemplares similares
-
Disulfide-Trapping Identifies a New, Effective Chemical Probe for Activating the Nuclear Receptor Human LRH-1 (NR5A2)
por: de Jesus Cortez, Felipe, et al.
Publicado: (2016) -
A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver
por: Suzawa, Miyuki, et al.
Publicado: (2015) -
The Herbicide Atrazine Activates Endocrine Gene Networks via Non-Steroidal NR5A Nuclear Receptors in Fish and Mammalian Cells
por: Suzawa, Miyuki, et al.
Publicado: (2008) -
Epithelial TNF controls cell differentiation and CFTR activity to maintain intestinal mucin homeostasis
por: Reyes, Efren A., et al.
Publicado: (2023) -
In vitro patterning of pluripotent stem cell-derived intestine recapitulates in vivo human development
por: Tsai, Yu-Hwai, et al.
Publicado: (2017)